BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 24014214)

  • 21. A comparison between a combination of letrozole and clomiphene citrate versus gonadotropins for ovulation induction in infertile patients with clomiphene citrateresistant polycystic ovary syndrome - a retrospective study.
    Ege S; Bademkıran MH; Peker N; Tahaoğlu AE; Hançer Çaça FN; Özçelik SM
    Ginekol Pol; 2020; 91(4):185-188. PubMed ID: 32236935
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Optimal Ovulation Induction in Polycystic Ovary Syndrome Resistant to Clomiphene Citrate or Letrozole.].
    Chen Y; Zhang D
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2016 Nov; 47(6):874-877. PubMed ID: 28598116
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A randomized controlled trial of combination letrozole and clomiphene citrate or letrozole alone for ovulation induction in women with polycystic ovary syndrome.
    Mejia RB; Summers KM; Kresowik JD; Van Voorhis BJ
    Fertil Steril; 2019 Mar; 111(3):571-578.e1. PubMed ID: 30683591
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The adjuvant effect of metformin and N-acetylcysteine to clomiphene citrate in induction of ovulation in patients with Polycystic Ovary Syndrome.
    Maged AM; Elsawah H; Abdelhafez A; Bakry A; Mostafa WA
    Gynecol Endocrinol; 2015; 31(8):635-8. PubMed ID: 26291797
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined coenzyme Q10 and clomiphene citrate for ovulation induction in clomiphene-citrate-resistant polycystic ovary syndrome.
    El Refaeey A; Selem A; Badawy A
    Reprod Biomed Online; 2014 Jul; 29(1):119-24. PubMed ID: 24813752
    [TBL] [Abstract][Full Text] [Related]  

  • 26. First-line ovulation induction for polycystic ovary syndrome: an individual participant data meta-analysis.
    Wang R; Li W; Bordewijk EM; Legro RS; Zhang H; Wu X; Gao J; Morin-Papunen L; Homburg R; König TE; Moll E; Kar S; Huang W; Johnson NP; Amer SA; Vegetti W; Palomba S; Falbo A; Özmen Ü; Nazik H; Williams CD; Federica G; Lord J; Sahin Y; Bhattacharya S; Norman RJ; van Wely M; Mol BW; ;
    Hum Reprod Update; 2019 Nov; 25(6):717-732. PubMed ID: 31647106
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A randomized controlled trial of the effect of rosiglitazone and clomiphene citrate versus clomiphene citrate alone in overweight/obese women with polycystic ovary syndrome.
    Mohsen IA
    Gynecol Endocrinol; 2012 Apr; 28(4):269-72. PubMed ID: 21970545
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Luteal phase clomiphene citrate for ovulation induction in women with polycystic ovary syndrome: a novel protocol.
    Badawy A; Inany H; Mosbah A; Abulatta M
    Fertil Steril; 2009 Mar; 91(3):838-41. PubMed ID: 18314112
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of letrozole and clomiphene citrate combined with gonadotropins in clomiphene-resistant infertile women with polycystic ovary syndrome: a prospective study.
    Xi W; Liu S; Mao H; Yang Y; Xue X; Lu X
    Drug Des Devel Ther; 2015; 9():6001-8. PubMed ID: 26648691
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Higher ovulation rate with letrozole as compared with clomiphene citrate in infertile women with polycystic ovary syndrome: a systematic review and meta-analysis.
    Tsiami AP; Goulis DG; Sotiriadis AI; Kolibianakis EM
    Hormones (Athens); 2021 Sep; 20(3):449-461. PubMed ID: 34033068
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clomifene citrate or low-dose FSH for the first-line treatment of infertile women with anovulation associated with polycystic ovary syndrome: a prospective randomized multinational study.
    Homburg R; Hendriks ML; König TE; Anderson RA; Balen AH; Brincat M; Child T; Davies M; D'Hooghe T; Martinez A; Rajkhowa M; Rueda-Saenz R; Hompes P; Lambalk CB
    Hum Reprod; 2012 Feb; 27(2):468-73. PubMed ID: 22128296
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clomiphene citrate and dexamethazone in treatment of clomiphene citrate-resistant polycystic ovary syndrome: a prospective placebo-controlled study.
    Elnashar A; Abdelmageed E; Fayed M; Sharaf M
    Hum Reprod; 2006 Jul; 21(7):1805-8. PubMed ID: 16543255
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Pregnancy in Polycystic Ovary Syndrome II (PPCOS II) trial: rationale and design of a double-blind randomized trial of clomiphene citrate and letrozole for the treatment of infertility in women with polycystic ovary syndrome.
    Legro RS; Kunselman AR; Brzyski RG; Casson PR; Diamond MP; Schlaff WD; Christman GM; Coutifaris C; Taylor HS; Eisenberg E; Santoro N; Zhang H;
    Contemp Clin Trials; 2012 May; 33(3):470-81. PubMed ID: 22265923
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clomiphene citrate before and after withdrawal bleeding for induction of ovulation in women with polycystic ovary syndrome: Randomized cross-over trial.
    Elbohoty AE; Amer M; Abdelmoaz M
    J Obstet Gynaecol Res; 2016 Aug; 42(8):966-71. PubMed ID: 27126971
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Highly purified FSH is as efficacious as recombinant FSH for ovulation induction in women with WHO Group II anovulatory infertility: a randomized controlled non-inferiority trial.
    Balen A; Platteau P; Andersen AN; Devroey P; Helmgaard L; Arce JC;
    Hum Reprod; 2007 Jul; 22(7):1816-23. PubMed ID: 17449511
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sequential clomiphene citrate/hMG versus hMG for ovulation induction in clomiphene citrate-resistant women.
    Abdelazim IA; Makhlouf HH
    Arch Gynecol Obstet; 2013 Mar; 287(3):591-7. PubMed ID: 23080548
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recombinant FSH in alternative doses or versus urinary gonadotrophins for ovulation induction in subfertility associated with polycystic ovary syndrome: a systematic review based on a Cochrane review.
    van Wely M; Bayram N; van der Veen F
    Hum Reprod; 2003 Jun; 18(6):1143-9. PubMed ID: 12773438
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Randomized controlled open-label study of the effect of vitamin E supplementation on fertility in clomiphene citrate-resistant polycystic ovary syndrome.
    Morsy AA; Sabri NA; Mourad AM; Mojahed EM; Shawki MA
    J Obstet Gynaecol Res; 2020 Nov; 46(11):2375-2382. PubMed ID: 32885585
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Extension of the clomiphene citrate stair-step protocol to gonadotropin treatment in women with clomiphene resistant polycystic ovarian syndrome.
    Horowitz E; Levran D; Weissman A
    Gynecol Endocrinol; 2017 Oct; 33(10):807-810. PubMed ID: 28454491
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recombinant follicle-stimulating hormone (FSH; Puregon) is more efficient than urinary FSH (Metrodin) in women with clomiphene citrate-resistant, normogonadotropic, chronic anovulation: a prospective, multicenter, assessor-blind, randomized, clinical trial. European Puregon Collaborative Anovulation Study Group.
    Coelingh Bennink HJ; Fauser BC; Out HJ
    Fertil Steril; 1998 Jan; 69(1):19-25. PubMed ID: 9457926
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.